{
    "date": "2018-04-21 00:00:00",
    "file_url": "sequences/inferred_sequence_2.xlsx",
    "content": {
        "Sequence": {
            "description_id": 2,
            "author": "Verity Stob",
            "lab_name": "Department of Immunotechnology",
            "lab_address": "HGDTS University, Town, Country",
            "release_version": 1,
            "release_description": "First release",
            "release_date": "2018-04-21 00:00:00",
            "pub_ids": "<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=25890375\" target=\"_blank\">25890375</a>",
            "organism": "homo sapiens",
            "gene_name": "IGHV5-2*02",
            "alt_names": null,
            "locus": "IGH",
            "region": "V",
            "functionality": "Functional",
            "inference_class": "Repertoire",
            "affirmation_level": 1,
            "status": "Active",
            "deprecation_reason": " ",
            "gene_subgroup": 5,
            "subgroup_designation": 21,
            "allele_designation": 2,
            "codon_frame": 1,
            "j_cdr3_end": null,
            "paralogs": " ",
            "observed_sequences": "BN000872.1",
            "genomic_sequences": " "
        },
        "Acknowledgements": [
            {
                "name": "Mel Smyth",
                "institution_name": "University of Kent",
                "ORCID_id": "0000-0003-1912-3935"
            },
            {
                "name": "Griff Jones",
                "institution_name": "RMIT University",
                "ORCID_id": "0000-0003-1912-3935"
            },
            {
                "name": "Anthony Minghella",
                "institution_name": "University of Texas MD Anderson Cancer Center",
                "ORCID_id": "0000-0003-1912-3935"
            }
        ],
        "Submissions": [
            {
                "id": "1",
                "url": "submissions/iarc_submission_1",
                "name": "IGHV5-2*02_002"
            },
            {
                "id": "2",
                "url": "submissions/iarc_submission_2",
                "name": "IGHV5_2*02_C181G"
            }
        ],
        "Meetings": [
            {
                "id": 3,
                "url": "meetings/iarc_meeting_3_26_1_18_minutes.pdf",
                "date": "2018-01-26",
                "filename": "iarc_meeting_3_26_1_18_minutes.pdf"
            },
            {
                "id": 4,
                "url": "meetings/iarc_meeting_4_2_2_18_minutes.pdf",
                "date": "2018-02-02",
                "filename": "iarc_meeting_4_2_2_18_minutes.pdf"
            },
            {
                "id": 5,
                "url": "meetings/iarc_meeting_5_16_2_18_minutes.pdf",
                "date": "2018-02-16",
                "filename": "iarc_meeting_5_16_2_18_minutes.pdf"
            },
            {
                "id": 7,
                "url": "meetings/iarc_meeting_7_9_3_18_minutes.pdf",
                "date": "2018-03-09",
                "filename": "iarc_meeting_7_9_3_18_minutes.pdf"
            }
        ],
        "file_url": "sequences/inferred_sequence_2.xlsx",
        "Notes": [
            "Lengthier notes on sequence 2",
            "",
            "im\u00b7mu\u00b7no\u00b7glob\u00b7u\u00b7lin (Ig), (im'y\u016b-n\u014d-glob'y\u016b-lin),",
            "One of a class of structurally related proteins, each consisting of two pairs of polypeptide chains, one pair of light (L) low molecular weight chains (\u03ba or \u03bb), and one pair of heavy (H) chains (\u03b3, \u03b1, \u03bc, \u03b4, and \u03b5), usually all four linked by disulfide bonds. On the basis of the structural and antigenic properties of the H chains, immunoglobulins are classified (in order of relative amounts present in normal human serum) as IgG (7S in size, 80%), IgA (10-15%), IgM (19S, a pentamer of the basic unit, 5-10%), IgD (less than 0.1%), and IgE (less than 0.01%). All of these classes are homogeneous and susceptible to amino acid sequence analysis. Each class of H chain can associate with either \u03ba or \u03bb L chains. Subclasses of immunoglobulin, based on differences in the H chains, are referred to as IgG1, etc.",
            "When split by papain, IgG yields three pieces: the Fc piece, consisting of the C-terminal portion of the H chains, with no antibody activity but capable of fixing complement, and crystallizable; and two identical Fab pieces, carrying the antigen-binding sites and each consisting of an L chain bound to the remainder of an H chain.",
            "Antibodies are immunoglobulins, and all immunoglobulins probably function as antibodies. However, immunoglobulin refers not only to the usual antibodies, but also to a great number of pathologic proteins classified as myeloma proteins, which appear in multiple myeloma along with Bence Jones proteins, myeloma globulins, and immunoglobulin fragments.",
            "From the amino acid sequences of Bence Jones proteins, it is known that all L chains are divided into a region of variable sequence (VL) and one of constant sequence (CL), each comprising about half the length of the L chain. The constant regions of all human L chains of the same type (\u03ba or \u03bb) are identical except for a single amino acid substitution, under genetic controls. H chains are similarly divided, although the VH region, although similar in length to the VL region, is only one third or one fourth the length of the CH region. Binding sites are a combination of VL and VH protein regions. The large number of possible combinations of L and H chains make up the \"libraries\" of antibodies of each individual."
        ],
        "fmt_raw": "1                                               50\ncaggttcagctggtgcagtctggagctgaggtgaagaagcctggggcctc\n\n51                                             100\nagtgaaggtctcctgcaaggcttctggttacacctttaccagctatggta\n\n101                                            150\ntcagctgggtgcgacaggcccctggacaagggcttgagtggatgggatgg\n\n151                                            200\natcagcgcttacaatggtaacacaaactatgcacagaagctccagggcag\n\n201                                            250\nagtcaccatgaccacagacacatccacgagcacagcctacatggagctga\n\n251                                        296\nggagcctgagatctgacgacacggccgtgtattactgtgcgagaga\n\n",
        "fmt_fa": ">IGHV5-2*02\ncaggttcagctggtgcagtctggagctgaggtgaagaagcctggggcctc\nagtgaaggtctcctgcaaggcttctggttacacctttaccagctatggta\ntcagctgggtgcgacaggcccctggacaagggcttgagtggatgggatgg\natcagcgcttacaatggtaacacaaactatgcacagaagctccagggcag\nagtcaccatgaccacagacacatccacgagcacagcctacatggagctga\nggagcctgagatctgacgacacggccgtgtattactgtgcgagaga\n",
        "fmt_imgt": "                                                                                                    \n 1   2   3   4   5   6   7   8   9   10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 \n Q   V   Q   L   V   Q   S   G   A       E   V   K   K   P   G   A   S   V   K   V   S   C   K   A  \ncag gtt cag ctg gtg cag tct gga gct ... gag gtg aag aag cct ggg gcc tca gtg aag gtc tcc tgc aag gct \n \n   _____________________CDR1_______________________                                                 \n 26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50 \n S   G   Y   T   F                   T   S   Y   G   I   S   W   V   R   Q   A   P   G   Q   G   L  \ntct ggt tac acc ttt ... ... ... ... acc agc tat ggt atc agc tgg gtg cga cag gcc cct gga caa ggg ctt \n \n                    _________________CDR2___________________                                        \n 51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75 \n E   W   M   G   W   I   S   A   Y           N   G   N   T   N   Y   A   Q   K   L   Q       G   R  \ngag tgg atg gga tgg atc agc gct tac ... ... aat ggt aac aca aac tat gca cag aag ctc cag ... ggc aga \n \n                                                                                                    \n 76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99 100 \n V   T   M   T   T   D   T   S   T   S   T   A   Y   M   E   L   R   S   L   R   S   D   D   T   A  \ngtc acc atg acc aca gac aca tcc acg agc aca gcc tac atg gag ctg agg agc ctg aga tct gac gac acg gcc \n \n                 _CDR3_____\n101 102 103 104 105 106    \n V   Y   Y   C   A   R     \ngtg tat tac tgt gcg aga ga \n ",
        "Sequence_order": [
            "description_id",
            "author",
            "lab_name",
            "lab_address",
            "release_version",
            "release_description",
            "release_date",
            "pub_ids",
            "organism",
            "gene_name",
            "alt_names",
            "locus",
            "region",
            "functionality",
            "inference_class",
            "affirmation_level",
            "status",
            "deprecation_reason",
            "gene_subgroup",
            "subgroup_designation",
            "allele_designation",
            "codon_frame",
            "j_cdr3_end",
            "paralogs",
            "observed_sequences",
            "genomic_sequences"
        ]
    }
}